Avinger Inc. (NASDAQ:AVGR) reached a new 52-week low on Thursday . The stock traded as low as $5.00 and last traded at $5.05, with a volume of 144,573 shares trading hands. The stock had previously closed at $5.16.

Several equities research analysts recently weighed in on the company. Zacks Investment Research lowered Avinger from a “hold” rating to a “sell” rating in a research report on Friday, July 15th. BTIG Research restated a “buy” rating and set a $18.00 price target on shares of Avinger in a research report on Friday, July 15th. Finally, Canaccord Genuity restated a “buy” rating on shares of Avinger in a research report on Tuesday, July 12th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. Avinger presently has a consensus rating of “Hold” and an average target price of $18.75.

The company’s market cap is $62.70 million. The company has a 50 day moving average of $9.75 and a 200-day moving average of $12.02.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($1.28) earnings per share for the quarter, missing the consensus estimate of ($1.17) by $0.11. On average, analysts anticipate that Avinger Inc. will post ($4.26) EPS for the current fiscal year.

In other news, Director Donald A. Lucas sold 9,309 shares of the stock in a transaction that occurred on Friday, May 6th. The stock was sold at an average price of $12.58, for a total value of $117,107.22. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Himanshu Patel sold 10,000 shares of the stock in a transaction that occurred on Friday, May 6th. The stock was sold at an average price of $13.40, for a total value of $134,000.00. Following the completion of the sale, the insider now owns 87,220 shares in the company, valued at $1,168,748. The disclosure for this sale can be found here.

A hedge fund recently bought a new stake in Avinger stock. Thornburg Investment Management Inc. purchased a new stake in Avinger Inc. (NASDAQ:AVGR) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 52,792 shares of the medical device company’s stock, valued at approximately $1,199,000. Thornburg Investment Management Inc. owned 0.42% of Avinger at the end of the most recent quarter.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.